Published in Gene Therapy Weekly, May 25th, 2006
"S. simulans by staphylolyticus secretes lysostaphin, a bacteriocin that cleaves pentaglycine cross bridges in the cell wall of S. aureus. The C-terminal cell wall-targeting domain (CWT) of lysostaphin is required for selective binding of this bacteriocin to S. aureus cells; however, the molecular target for this was unknown," wrote A. Grundling and colleagues, University of Chicago.
"We used purified green fluorescent protein fused to CWT (GFP-CWT) to reveal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly